Welcome to CDC stacks | Protocolized fluid therapy in brain-dead donors: The multi-center randomized MOnIToR trial - 30520 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Protocolized fluid therapy in brain-dead donors: The multi-center randomized MOnIToR trial
Filetype[PDF-670.25 KB]


Details:
  • Corporate Authors:
    on behalf of the Monitoring Organ Donors to Improve Transplantation Results (MOnIToR) Study Investigators
  • Pubmed ID:
    25583616
  • Pubmed Central ID:
    PMC4351113
  • Description:
    BACKGROUND

    Critical shortages of organs for transplantation jeopardize many lives. Observational data suggest that better fluid management for deceased organ donors could increase organ recovery. We conducted the first large multi-center randomized trial in brain-dead donors to determine whether protocolized fluid therapy increases organs transplanted.

    METHODS

    We randomly assigned donors to either protocolized or usual care in eight organ procurement organizations. A “protocol-guided fluid therapy” algorithm targeting cardiac index, mean arterial pressure and pulse pressure variation was used. Our primary outcome was the number of organs transplanted per donor and our primary analysis was intention-to-treat. Secondary analyses included: 1) modified intention-to-treat where only subjects able to receive the intervention were included, and 2) twelve-month survival in transplant recipients. The study was stopped early.

    RESULTS

    We enrolled 556 donors; 279 protocolized care, 277 usual care. Groups had similar characteristics at baseline. The study protocol could be implemented in 76% of subjects randomized to the intervention. There was no significant difference in mean number of organs transplanted per donor: 3.39 organs per donor, (95%CI: 3.14-3.63) with protocolized care, compared to usual care 3.29 (95%CI: 3.04-3.54) (mean difference, 0.1, 95%CI: -0.25 to 0.45; p=0.56). In modified intention-to-treat analysis the mean number of organs increased (3.52 organs per donor, 95%CI: 3.23-3.8) but was not statistically significant (mean difference, 0.23, 95%CI: -0.15-0.61; p=0.23). Among the 1430 recipients of organs from study subjects, with data available, 56 deaths (7.8%) occurred in the protocolized care arm and 56 (7.9%) in the usual care arm in the first year (Hazard Ratio: 0.97, p=0.86).

    CONCLUSIONS

    In brain-dead organ donors, protocol-guided fluid therapy compared to usual care may not increase the number of organs transplanted per donor.

  • Document Type:
  • Collection(s):
  • Funding:
    R01 DK083961/DK/NIDDK NIH HHS/United States
    R01DK083961/DK/NIDDK NIH HHS/United States
    R38OT1058/OT/OSTLTS CDC HHS/United States
    UL1 RR024153/RR/NCRR NIH HHS/United States
    UL1TR000005/TR/NCATS NIH HHS/United States
No Related Documents.
You May Also Like: